Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that Telogen Effluvium is a hair loss disorder that can be assessed with the modified wash test and may be treated with clobetasol foam, with patient management being important.

Hair loss in Telogen effluvium is often chronic, linked to stress, and lacks a confirmed treatment, but topical corticosteroids may be used.

Alfredo Rebora suggested a new, easier way to classify hair loss in Telogen Effluvium, adding a type possibly related to autoimmune diseases.

After severe COVID-19, 71% of patients experienced excessive hair shedding and thinning within 3 months due to factors like low oxygen levels, medication, stress, and autoimmune disease.

The document concludes that alopecia has significant social and psychological effects, leading to a market for hair loss treatments.

Telogen Effluvium is a common hair loss condition, particularly in women, with no specific FDA-approved treatment, and recovery can take up to 18 months.

Dermoscopy shows that diffuse alopecia areata progresses through specific hair growth stages.

Hair loss in cancer patients can be related to the cancer itself, treatment, or other conditions, and understanding it is important for diagnosis and patient care.

The article concludes that different types of hair loss require specific treatments and psychological support is important.

Topical drugs and near-infrared light therapy show potential for treating alopecia.

People with hair loss conditions may also have thyroid disorders, but more research is needed to understand the connection.

The document explains hair growth and shedding, factors affecting it, and methods to evaluate hair loss, emphasizing the importance of skin biopsy for diagnosis.

Hair growth and shedding are linked and can be disrupted, causing a delay known as the hair eclipse phenomenon, which is common in certain hair conditions and could lead to new treatments.

Healthy women tend to lose more hair in July and April, and the least in February.

AGA causes hair loss by shrinking hair follicles due to DHT binding, and can be treated with finasteride and minoxidil.

Male pattern baldness worsens with age and can be treated with medications like minoxidil and finasteride, but side effects and personalized care are important.

Hair loss peaks in spring and regrowth in late summer, with pregnant females losing the most hair.

The article concludes that developing in vitro models for human hair structures is important for research and reducing animal testing, but there are challenges like obtaining suitable samples and the models' limitations.

A systematic approach is crucial for managing hair loss in women.

EPR spectroscopy showed that spontaneous hair growth results in thicker skin and less pigmented hair than depilation-induced growth.

Telogen Effluvium is a hair loss condition where treatment involves identifying and managing its triggers.

Understanding hair follicle biology and stem cell control could lead to new hair loss treatments.

Low-level laser therapy may improve hair regrowth and thickness for androgenetic alopecia, but more research is needed.

Understanding hair biology is key to developing better treatments for hair and scalp issues.

Using 448-kHz Capacitive-Resistive Electrothermal Therapy can help increase hair density and prevent hair loss in women.

Algal oligosaccharides help prevent hair loss and promote hair growth.

Vitamin A deficiency changes cattle hair structure, while pregnancy may improve it, suggesting hair can indicate cattle health.

The conclusion is that future hair loss treatments should target the root causes of hair thinning, not just promote hair growth.

Different types of dog hair loss are linked to problems starting the hair growth phase and early hair cycle ending.

Dandruff is mainly caused by a scalp reaction to yeast, can worsen hair loss, and antifungal treatments may help.